Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stockholm - Delayed Quote SEK

Oncopeptides AB (publ) (ONCO.ST)

Compare
1.6660
-0.0400
(-2.34%)
At close: April 4 at 5:29:31 PM GMT+2
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
244,192
238,378
385,323
439,376
Total Liabilities Net Minority Interest
189,907
181,598
91,030
228,508
Total Equity Gross Minority Interest
54,285
56,780
294,293
210,868
Total Capitalization
176,179
163,267
294,293
210,868
Common Stock Equity
54,285
56,780
294,293
210,868
Capital Lease Obligations
--
19,669
9,542
14,193
Net Tangible Assets
54,285
56,780
294,293
209,460
Working Capital
165,726
157,967
278,362
187,084
Invested Capital
176,179
163,267
294,293
210,868
Tangible Book Value
54,285
56,780
294,293
209,460
Total Debt
121,894
126,156
9,542
14,193
Share Issued
211,263.9030
132,744.6840
132,336.6140
105,650.9880
Ordinary Shares Number
211,263.9030
126,906.6590
126,807.0770
105,650.9880
Treasury Shares Number
--
5,838.0250
5,529.5370
--
12/31/2021 - 2/22/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers